Viatris agrees to buy Pacira for $36.50 a share

Viatris entered into a merger agreement with Pacira BioSciences under which a Viatris subsidiary will launch a tender offer to acquire all Pacira shares for $36.50 each in cash. The deal is subject to customary conditions, including HSR review and a minimum tender condition.